By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Bloodno. Supplement 1 (2024): 4966-4966
0
0
bioRxiv the preprint server for biology (2024)
WOS
0
0
Load More
Saul H. Rosenberg
Executive Director
AbbVie
Follow
Claim
分享
Follow
Claim
分享
基本信息
views: 145
Career TrajectoryBio
His scientific interests lie mostly in Cancer research, Apoptosis, Pharmacology, In vivo and Navitoclax. His studies deal with areas such as Cell culture, Survivin, Immunology, Cell cycle and Regulation of gene expression as well as Cancer research. His Apoptosis study contributes to a more complete understanding of Biochemistry.
His In vivo research includes themes of Platelet and Paclitaxel. His work carried out in the field of Navitoclax brings together such families of science as Venetoclax, Survival analysis, Leukemia and Neutropenia. Saul H. Rosenberg has included themes like Oral administration and Obatoclax in his BH3 Mimetic ABT-737 study.
His In vivo research includes themes of Platelet and Paclitaxel. His work carried out in the field of Navitoclax brings together such families of science as Venetoclax, Survival analysis, Leukemia and Neutropenia. Saul H. Rosenberg has included themes like Oral administration and Obatoclax in his BH3 Mimetic ABT-737 study.
Research Interests
Author Statistics
#Papers: 430
#Citation: 33162
H-Index: 75
G-Index: 178
Sociability: 7
Diversity: 3
Activity: 56
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn